UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020340 |
|---|---|
| Receipt number | R000023495 |
| Scientific Title | A multicenter, investigator-initiated phase II clinical trial involving administration of a cross-linked gelatin hydrogel containing recombinant human basic fibroblast growth factor (rh-bFGF) to prevent the collapse of the femoral head |
| Date of disclosure of the study information | 2015/12/25 |
| Last modified on | 2019/01/07 16:31:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/12/25 13:23:16 | ||
| 2 | Update | 2015/12/25 13:28:15 | Date of disclosure of the study information |
|
| 3 | Update | 2015/12/28 15:49:42 | Public title Acronym Acronym |
|
| 4 | Update | 2015/12/28 15:51:04 | Narrative objectives1 |
|
| 5 | Update | 2016/01/13 19:02:31 | Key exclusion criteria Key exclusion criteria |
|
| 6 | Update | 2016/01/13 19:03:32 | Recruitment status |
|
| 7 | Update | 2016/03/08 16:38:01 | Organization3 Address3 Tel3 Email3 |
|
| 8 | Update | 2016/03/08 16:40:39 | URL releasing protocol |
|
| 9 | Update | 2016/03/08 16:44:01 | URL releasing protocol Other related information |
|
| 10 | Update | 2016/03/08 16:47:26 | URL releasing protocol Other related information |
|
| 11 | Update | 2016/12/01 19:27:50 | Recruitment status |
|
| 12 | Update | 2017/06/26 09:28:01 | Name of primary person or sponsor Department Organization Category of Funding Organization |
|
| 13 | Update | 2017/06/26 09:28:01 | Name of primary person or sponsor Department Organization Category of Funding Organization |
|
| 14 | Update | 2019/01/07 16:31:05 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
